ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Cue Biopharma Inc

Cue Biopharma Inc (CUE)

1.02
0.00
(0.00%)
마감 25 11월 6:00AM
1.03
0.01
(0.98%)
시간외 거래: 9:20AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
1.02
매수가
1.03
매도가
1.10
거래량
-
0.00 일간 변동폭 0.00
0.45 52주 범위 3.2491
market_cap
전일 종가
1.02
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
772,381
발행 주식
63,350,327
배당수익률
-
주가수익률
-1.27
주당순이익(EPS)
-0.8
매출
5.49M
순이익
-50.73M

Cue Biopharma Inc 정보

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CUE. The last closing price for Cue Biopharma was US$1.02. Over the last year, Cue Biopharma shares have traded in a share price range of US$ 0.45 to US$ 3.2491.

Cue Biopharma currently has 63,350,327 shares in issue. The market capitalisation of Cue Biopharma is US$64.62 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.27.

CUE 최신 뉴스

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...

Cue Biopharma Announces Strategic Organizational Transition

Daniel Baker, M.D., will join Cue Biopharma’s executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific...

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

Objective response rate (ORR) of 46%, 12-month overall survival (OS) of 91.3% and a median overall survival (mOS) of 21.8 months in first line (1L) HPV+ R/M HNSCC patients treated with CUE-101 and...

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.23-18.41.251.371.025448971.07034622CS
4-0.44-30.13698630141.461.98911.026976211.51451884CS
120.297541.17647058820.72251.98910.457723811.2591635CS
26-0.64-38.55421686751.661.98910.455947031.15975334CS
52-1.39-57.67634854772.413.24910.454576981.55965474CS
156-12.05-92.195868400913.0713.530.453598753.29573567CS
260-9.02-89.840637450210.0435.50.453378087.94707505CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AALAmerican Airlines Group Inc
US$ 14.38
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67.50
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.30
(0.00%)
0
AACGATA Creativity Global
US$ 1.02
(0.00%)
0
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M

CUE Discussion

게시물 보기
Hawkeye_tt Hawkeye_tt 1 월 전
TY for that quick dip/Algo dump op. Took advantage big time.
GL all...

Hawk
👍️0
boston127 boston127 2 월 전
Momentum for CUE is waning,

as measured by a 14-period Slow Stochastic Oscillator. This means that investors are less aggressive in their recent purchases and may even be taking profits in positions bought at lower prices.
👍️0
boston127 boston127 2 월 전
The On Balance Volume indicator (OBV) is bullish.

The slope of the indicator is positive and suggests that buyers are presently more active than sellers.Today's volume was heavier than usual, trading 2,320,021 shares, versus an average of 389,835 shares per day during the last twelve months.
👍️0
boston127 boston127 2 월 전
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic oscillator is above 80, the level which many analysts call overbought. This means that investors have been actively purchasing shares and driving the price higher.
👍️0
boston127 boston127 2 월 전
I got in on Friday. Everything

about the company is good. Gotta love it. They did not give up much to get that $11M in financing. Will buy on dips. Bought a little more today.
👍️0
Monksdream Monksdream 2 월 전
CUE under $2
👍️0
Hawkeye_tt Hawkeye_tt 2 월 전
Look at that Wkly candle ! Vol fantastic.
LT outlook back on !

Hawk
👍️0
Triple nickle Triple nickle 2 월 전
CUE ready to win 1.02
👍️0
Hawkeye_tt Hawkeye_tt 2 월 전
Strong recovery on news....future looking good here. Buy, hold LT...
Hawk
👍️0
Monksdream Monksdream 5 월 전
CUE new 52 week low
👍️0
Hawkeye_tt Hawkeye_tt 2 년 전
CUE....this story grows quickly. Merck early investor.
Last few wks it has been breaking out.
$5 break next. More Partners want in, on top of Ono.

Hawk
👍️0
conix conix 3 년 전
CUE Insider Buy
Cue Biopharma Aaron G.L. Fletcher Director Buy 735,000 shares @ $4.76 $3,498,600.00 3/31/2022
👍️0

최근 히스토리

Delayed Upgrade Clock